Cannabis
Offering Employees a Holistic Approach to Healthcare Through Access to Medical Cannabis
In 2001, the Canadian government launched the Canadian Medical Marijuana Access Regulations Program allowing patients across the country safe access to medical cannabis. In 2016, the program was extended to permit medical patients in Canada to attain a “Grow Your Own License”, legally permitting patients to grow their own cannabis at home. Fast forward to 2020, there is an increasing amount of research focusing on the medical benefits of cannabis and cannabinoids, such as THC and CBD — these treatment options being accessed by patients experiencing a wide variety of medical conditions.
Medical cannabis patients often cite the cost of medical cannabis and the lack of healthcare coverage as a barrier for becoming a patient. Maximus Rose Living Benefits, a company that started in Northern Ontario and has expanded to Southern Ontario, recognized a gap in healthcare services in terms of employee benefits plans. With their understanding of marketplace trends, they realized the importance of offering their clients’ safe and discrete access to medical cannabis solutions as a necessary next step. Evidence shows that proper medical oversight when using medical cannabis can increase successful outcomes for patients versus self-medicating.
“Maximus Rose is proud to partner with Medical Marijuana Consultants to provide our clients with Virtual Marijuana Consulting Services as well as access to the highest industry standard of medical cannabis,” explains Tony Fasulo, CEO of Maximus Rose. “We want to offer our clients’ and their employees a variety of pharmaceutical and relief options, and that includes a holistic approach to healthcare through access to medical cannabis.”
Medical Marijuana Consultants (MMC), a Sensi Brands company, has been supporting medical cannabis patients since 2014, providing a “white glove” full-service offering. MMC provides access to medical cannabis prescriptions to eligible patients through their team of experienced healthcare practitioners and dedicated patient case managers. They also provide education and ongoing support throughout the patients’ treatment journey and ensures patients can access reimbursements through their health benefits. MMC’s Patient Care team works with patients of all backgrounds, with a focus on motor vehicle accident patients and Canadian Armed Forces Veterans with unique needs. Medical cannabis has been shown to provide relief for: Chronic Pain, Cancer Treatment, Anxiety, Depression, Stress, PTSD, Sleep Disorders, Inflammation, Back Pain, Migraines, Epilepsy & more.
“We are thrilled to have this unique opportunity to be the exclusive partner with Maximus Rose providing our best-in-class medical cannabis services to their clients and employees.” said Tony Giorgi, CEO of Sensi Brands, MMC’s parent company, “We firmly believe that by providing patients with the right support and medical oversight, patients can have better outcomes leading to improved lifestyles and more productive employees.”
For more information about MR and MMC, visit www.maximusrose.com and www.medmc.ca.
SOURCE Maximus Rose Living Benefits
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis5 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE6 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis5 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Humboldt5 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis3 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III